IP Library Granted Patent US 7,670,809
Granted Patent B2
US 7,670,809 · App. 10/416,424 · Granted Mar 2, 2010

Use of mutagenic DNA polymerase for producing random mutations

Assignee: Millegen
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,809
App. No.
10/416,424
Granted
Mar 2, 2010
Kind
B2
Abstract

The invention concerns a method for random mutagenesis comprising the replication of a DNA sequence in the presence of an efficient amount of at least a mutase, for example a Pol β, the random mutagenesis rate being at least of the order of 1 mutation for 400 base pairs. The replication product, optionally recombined and amplified, is cloned in an expression vector so as to generate mutated polypeptides which will be selected on the basis of the desired property or properties.

Claims (31)

1. A method of random mutagenesis comprising steps of:

(i) replicating a DNA sequence with an effective amount of at least one mutase in order to generate random mutations within the replicated DNA sequence, wherein the at least one mutase is selected from the group consisting of DNA polymerases beta, iota, eta and kappa;

(ii) amplifying by PCR the replicated DNA using a DNA polymerase other than those recited in step (i);

(iii) cloning the amplified DNA sequence into an expression vector; and

(iv) generating a library of mutated polypeptides.

2. The method of claim 1 , wherein the at least one mutase is DNA polymerase beta.

3. The method of claim 1 , wherein the at least one mutase is used in the form of a cell extract.

4. The method of claim 1 , wherein several mutases selected from the group consisting of DNA polymerases beta, iota, eta and kappa are used simultaneously in the DNA replication in step (i).

5. The method of claim 1 , wherein several mutases selected from the group consisting of DNA polymerases beta, iota, eta and kappa are used successively in the DNA replication in step (i).

6. The method of claim 1 , wherein random mutations within the replicated DNA sequence are generated with a frequency at least of the order of 1 mutation per 400 base pairs.

7. The method of claim 6 , wherein the frequency is at least of the order of 1 mutation per 300 base pairs.

8. The method of claim 7 , wherein the frequency is at least of the order of 1 mutation per 200 base pairs.

9. The method of claim 8 , wherein the frequency is at least of the order of 1 mutation per 100 base pairs.

10. The method of claim 9 , wherein the frequency is at least of the order of 1 mutation per 50 base pairs.

11. The method of claim 9 , wherein the DNA replication in step (i) is followed by a recombination step.

12. The method of claim 1 , wherein nucleotides selected from the group consisting of a biased nucleotide pool, one mutagenic nucleotide analog, several mutagenic nucleotide analogs and/or any combination thereof are used in the DNA replication in step (i).

13. The method of claim 1 , wherein an element selected from the group consisting of manganese and cobalt is used during the PCR amplification of step (ii).

14. The method of claim 1 , wherein cloning the amplified DNA sequence into an expression vector comprises steps of:

synthesizing the mutated polypeptides; and

isolating the mutated polypeptides synthesized.

15. The method of claim 14 , wherein the amplified DNA sequence is recombined before being cloned.

16. The method of claim 14 , wherein mutated polypeptides exhibiting a desired property or desired properties are selected.

17. The method of claim 1 , wherein the DNA replication in step (i) involves replicating a DNA sequence carried by a plasmid.

18. The method of claim 1 , wherein the DNA replication in step (i) is stopped with a stop buffer prior to commencement of the PCR amplification in step (ii).

19. The method of claim 1 , wherein the DNA replication in step (i) is carried out a temperature less than 70°C., and the PCR amplification in step (ii) is carried out at a temperature greater than 70°C.

20. The method of claim 1 , wherein the polymerase used for the DNA replication in step (i) is stable only at a temperature less than 70°C., and the polymerase used for the PCR amplification in step (ii) is stable at a temperature greater than 70°C.

21. A method of random mutagenesis comprising steps of:

(i) replicating a DNA sequence with an effective amount of at least one mutase to generate random mutations within the replicated DNA sequence, wherein the at least one mutase is selected from the group consisting of DNA polymerases iota, eta and kappa;

(ii) amplifying by PCR the replicated DNA using a DNA polymerase other than those recited in step (i)

(iii) cloning the amplified DNA sequence into an expression vector; and

(iv) generating a library of mutated polypeptides.

Assignments (4)
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Apr 3, 2023
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 063237/0439 →
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Sep 21, 2022
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 061493/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2014
From: MILLEGEN
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT AND DES BIOTECHNOLOGIES
Reel/Frame 034059/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2003
From: BOUAYADI, KHALIL; KHARRAT, HAKIM; LOUAT, THIERRY; SERVANT, LAURENCE; CAZAUX, CHRISTOPHE; HOFFMANN, JEAN SEBASTIEN
To: MILLEGEN
Reel/Frame 014688/0811 →
Priority Claims (1)
FR 00 14333 · Nov 8, 2000 · national
Continuity (1)
Related Publication 20040110294A1 · Jun 10, 2004